Effect of Antenatal Corticosteroids on Fetal Growth and Gestational Age at Birth
- 1 May 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 119 (5), 917-923
- https://doi.org/10.1097/aog.0b013e31825189dc
Abstract
To estimate the effect of multiple courses of antenatal corticosteroids on neonatal size, controlling for gestational age at birth and other confounders, and to determine whether there was a dose-response relationship between number of courses of antenatal corticosteroids and neonatal size. This is a secondary analysis of the Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study, a double-blind randomized controlled trial of single compared with multiple courses of antenatal corticosteroids in women at risk for preterm birth and in which fetuses administered multiple courses of antenatal corticosteroids weighed less, were shorter, and had smaller head circumferences at birth. All women (n=1,858) and children (n=2,304) enrolled in the Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study were included in the current analysis. Multiple linear regression analyses were undertaken. Compared with placebo, neonates in the antenatal corticosteroids group were born earlier (estimated difference and confidence interval [CI]: -0.428 weeks, CI -0.10264 to -0.75336; P=.01). Controlling for gestational age at birth and confounding factors, multiple courses of antenatal corticosteroids were associated with a decrease in birth weight (-33.50 g, CI -66.27120 to -0.72880; P=.045), length (-0.339 cm, CI -0.6212 to -0.05676]; P=.019), and head circumference (-0.296 cm, -0.45672 to -0.13528; P<.001). For each additional course of antenatal corticosteroids, there was a trend toward an incremental decrease in birth weight, length, and head circumference. Fetuses exposed to multiple courses of antenatal corticosteroids were smaller at birth. The reduction in size was partially attributed to being born at an earlier gestational age but also was attributed to decreased fetal growth. Finally, a dose-response relationship exists between the number of corticosteroid courses and a decrease in fetal growth. The long-term effect of these findings is unknown. ClinicalTrials.gov, www.clinicaltrials.gov, NCT00187382. II.Keywords
This publication has 11 references indexed in Scilit:
- Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study: 2-Year OutcomesPEDIATRICS, 2010
- Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trialThe Lancet, 2008
- Long-Term Outcomes after Repeat Doses of Antenatal CorticosteroidsThe New England Journal of Medicine, 2007
- Outcomes at 2 Years of Age after Repeat Doses of Antenatal CorticosteroidsThe New England Journal of Medicine, 2007
- Randomized Trial of a Single Repeat Dose of Prenatal Betamethasone Treatment in Imminent Preterm BirthPEDIATRICS, 2007
- Single versus weekly courses of antenatal corticosteroids: Evaluation of safety and efficacyAmerican Journal of Obstetrics and Gynecology, 2006
- Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trialThe Lancet, 2006
- Repeated doses of antenatal corticosteroids in animals: A systematic reviewAmerican Journal of Obstetrics and Gynecology, 2002
- Single vs Weekly Courses of Antenatal Corticosteroids for Women at Risk of Preterm DeliveryJama-Journal Of The American Medical Association, 2001
- PREMATURE DELIVERY OF FOETAL LAMBS INFUSED WITH GLUCOCORTICOIDSJournal of Endocrinology, 1969